Archives of Gynecology and Obstetrics

, Volume 282, Issue 1, pp 11–15 | Cite as

A randomised controlled study comparing Drotaverine hydrochloride and Valethamate bromide in the augmentation of labour

  • Chendrimada Madhu
  • Suvarna Mahavarkar
  • Sudhir Bhave
Materno-fetal Medicine



Cervical dilatation is a poorly understood process. Various drugs have been used to facilitate this process and reduce the duration of labour and thereby reduce feto-maternal complications. The present study is an attempt to compare and evaluate the efficacy of Drotaverine hydrochloride and Valethamate bromide in the process of cervical dilatation and labour augmentation.

Study design

A prospective randomised trial of 146 low-risk women in spontaneous labour was conducted. 49 women were given Drotaverine (Group 1), 49 women were given Valethamate (Group 2) and 48 women were given placebo (Group 3). At 4 cm of cervical dilatation, elective amniotomy was done and the injection was given intramuscularly, and repeated every hour for a maximum of three doses.


There was a statistically significant difference in the mean injection–delivery times (time from first injection to delivery of the baby), which was 183.2 min (SD 78.8) in the Drotaverine group compared to 206.5 min (SD 69.7) in the Valethamate group, and 245 min (SD 70.9) in the control group. The mean cervical dilatation rate (cm/h) was 3 (SD 1.4), 2.4 (SD 0.9) and 1.9 (SD 0.6) in groups 1, 2 and 3, respectively, and these differences were statistically significant. There were no statistically significant differences in the duration of second and third stage of labour. Transient side effects such as foeto-maternal tachycardia, flushing of the face and dryness of mouth were noted with Valethamate. A few patients complained of headache in the Drotaverine group.


Both Drotaverine and Valethamate appear to significantly help cervical dilatation and augment first stage of labour. But, Drotaverine is superior to Valethamate with fewer side effects.


Drotaverine hydrochloride Valethamate bromide Augmentation of labour Cervical dilatation 


Conflict of interest statement



  1. 1.
    O’Driscoll K et al (1973) Active management of labour. Br Med J. 3:135–137CrossRefPubMedGoogle Scholar
  2. 2.
    Socol M, Peaceman AM (1999) Active management of labour. Obstet Gynaecol Clin North Am 26(2):287–294CrossRefGoogle Scholar
  3. 3.
    Brown HC, Paranjothy S, Dowswell T, Thomas J (2008) Package of care for active management in labour for reducing caesarean section rates in low-risk women. Cochrane Database Syst Rev (4):CD004907Google Scholar
  4. 4.
    Sadler LC, Davison T, McCowan LM (2000) A randomized controlled trial and meta-analysis of active management of labour. BJOG 107(7):909–915CrossRefPubMedGoogle Scholar
  5. 5.
    Samuels LA, Chritie L, Roberts-Gittens B, Fletcher H, Frederick J (2007) The effect of hyoscine butylbromide on the first stage of labour in term pregnancies. BJOG 114(12):1542–1546CrossRefPubMedGoogle Scholar
  6. 6.
    Boulvan M, Kelly A, Lohse C, Stan C, Irion O (2001) Mechanical methods for induction of labour. Cochrane Database Syst Rev (4):CD001233Google Scholar
  7. 7.
    Sharma JB, Pundir P, Kumar A, Murthy NS (2001) Drotaverine hydrochloride vs. Valethamate bromide in acceleration of labour. Int J Gynecol Obstet 74:255–260CrossRefGoogle Scholar
  8. 8.
    Singh KC, Jain P, Goel N, Saxena A (2004) Drotaverine hydrochloride for the augmentation of labour. Int J Gynecol Obstet 84:17–22CrossRefGoogle Scholar
  9. 9.
    Roy A, Patra KK, Mukhopadhyay S, Guha S (2007) Study of drotaverine on first stage of labour and pregnancy outcome. J Indian Med Assoc 105(8):450–452PubMedGoogle Scholar
  10. 10.
    Kuruvilla S et al (1992) A randomised controlled trial of Valethamate bromide in the acceleration of labour. Int J Gynaecol Obstet 38:93–96CrossRefGoogle Scholar
  11. 11.
    Ambiye VR, Alwani CM, Sinha R (1987) Valethamate bromide for the acceleration of labour. J Obstet Gynaecol Ind 35:852–854Google Scholar
  12. 12.
    Kaur D, Saini AS, Lata S (1998) Effect of intravenous infusion of Epidosin on labour. J Obstet Gynecol Ind 45:708–710Google Scholar
  13. 13.
    Leroy MI et al (1994) Isolation and characterization of the rolipram sensitive cAMP specific phophodiesterase (Type IV PDE) in human myometrium. Cell signal 6:405–412CrossRefPubMedGoogle Scholar
  14. 14.
    Hughesdon PE (1951) Anatomy of the human cervix in pregnancy. Proc R Soc Med 44(10):871–872PubMedGoogle Scholar
  15. 15.
    Naftolin F, Stubblefield PG (1980) The ultra structure of the human cervix. Raven Press, New YorkGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Chendrimada Madhu
    • 1
    • 2
  • Suvarna Mahavarkar
    • 1
    • 3
  • Sudhir Bhave
    • 1
  1. 1.Government Medical CollegeMirajIndia
  2. 2.Colchester Hospital University Foundation TrustColchesterUK
  3. 3.Queen’s HospitalsRomfordUK

Personalised recommendations